The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors

Journal of Trace Elements in Medicine and Biology

Volumn 25, Issue 3, 2011, Pages 154-159

  Jia, Chunshu ^a   Chen, Xiaoliang ^a   Li, Xiangjun ^a   Li, Min ^a   Miao, Chunsheng ^a   Sun, Bo ^a   Fan, Zhimin ^a   Ren, Liqun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Dehydroepiandrosterone; Keshan disease; Selenium; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CONNECTIVE TISSUE GROWTH FACTOR; CREATINE KINASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; PRASTERONE; SELENIUM; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOMYOPATHY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; EXTRACELLULAR MATRIX; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; KESHAN DISEASE; METABOLIC INHIBITION; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; TREATMENT OUTCOME;

ANIMALS; BODY WEIGHT; CARDIOMYOPATHIES; CONNECTIVE TISSUE GROWTH FACTOR; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; ENTEROVIRUS INFECTIONS; EXTRACELLULAR MATRIX; FIBROSIS; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; ORGAN SIZE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 80052739604     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.04.001     Document Type: Article

References (33)

1. Ge K., Yang G. The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 1993, 57(2 Suppl.):259S-263S.
2. Li G.S., Wang F., Kang D., Li C. Keshan disease: an endemic cardiomyopathy in China. Hum Pathol 1985, 16(6):602-609.
3. Gu B.Q. Pathology of Keshan disease. A comprehensive review. Chin Med J 1983, 96(4):251-261.
4. Wang F., Li G.S., Li C., An R.G., Yang T.S., Zhu P. Pathogenic factors of Keshan disease in the grains cultivated in endemic areas. Proceedings of the third international symposium on selenium in biology and medicine 1984, 896-901. Von Nostrand Reinhold, New York, NY. J.F. Combs, D.A. Levander, J.E. Spallholz, J.E. Oldfield (Eds.).
5. Levander O.A., DeLoach D.P., Morris V.C., Moser P.B. Platelet glutathione peroxidase activity as an index of selenium status in rats. J Nutr 1983, 113(1):55-63.
6. Liebler D.C., Kling D.S., Reed D.J. Antioxidant protection of phospholipid bilayers by alpha-tocopherol. Control of alpha-tocopherol status and lipid peroxidation by ascorbic acid and glutathione. J Biol Chem 1986, 261(26):12114-12119.
7. Peng T.Q., Li Y.W., Yang Y.Z., Niu C.L., Capner P.M., Archard L.C., et al. Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China. J Clin Microbiol 2000, 38(10):3538-3543.
8. Mccord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163.
9. Le C.T., Hollaar L., van der Valk E.J., van der Laarse A. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxidederived free radical attack. J Mol Cell Cardiol 1993, 25:519-528.
10. Toussaint O., Houbion A., Remacle J. Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity. Toxicology 1993, 81:89-101.
11. Bastianetto S., Quirion R. Any facts behind the DHEA hype?. Trends Pharmacol Sci 1997, 18(12):447-449.
12. Barrett C.E., Khaw K.T., Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986, 315(24):1519-1524.
13. Iwasaki Y., Asai M., Yoshida M., Nigawara T., Kambayashi M., Nakashima N. Dehydroepiandrosterone-sulfate inhibits nuclear factor κB-dependent transcription in hepatocytes possibly through antioxidant effect. J Endocrinol Metab 2005, 89(7):3449-3454.
14. Yorek M.A., Coppey L.J., Gellett J.S., Davidson E.P., Bing X.Y., Lund D.D., et al. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 2002, 283(5):1067-1075.
15. Yildirim A., Gumus M., Dalga S., Sahin Y.N., Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. ACLS 2003, 33(4):459-464.
16. Barger S.W., Chavis J.A., Drew P.D. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res 2000, 62:503-509.
17. Ren L.Q., Li X.J., Li G.S., Zhao Z.T., Sun B., Sun F. Coxsackievirus B3 infection and its mutation in Keshan disease. World J Gastroenterol 2004, 10(22):3299-3302.
18. Sun S.Q. Chronic exposure to cereal mycotoxin likely citreoviridin may be a trigger for Keshan disease mainly through oxidative stress mechanism. Med Hypotheses 2010, 74:841-842.
19. Yue L.J., Xiao S.F., Wang F., Zhang X.Y., Li G.S. Changes of thyroid hormone metabolism in Wistar rats fed with the artificial semisynthetic forage of low selenium and low vitamin E. Chin J Endemiol 1996, 15(3):143-146.
20. Boccuzzi G., Brignardello E., Massobrio M., Bonino L. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. Eur J Cancer Clin Oncol 1987, 23(8):1099-1102.
21. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., et al. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 2008, 149(1):380-388.
22. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179(73):588-590.
23. Gallo C., Renzi P., Loizzo S., Loizzo A., Piacente S., Festa M., et al. Potential therapeutic effects of vitamin E and C on placental oxidative stress induced by nicotine: an in vitro evidence. Open Biochem J 2010, 24(4):77-82.
24. Liu S.Y., Wang F. Damage to hepatic thyroxine 5'deiodination induced by pathogenic factors of Keshan disease and preventive effects of selenium and vitamin E. Biomed Environ Sci 1991, 4:359-365.
25. Tong W.M., Wang F. Alterations in rat pancreatic islet β cells induced by Keshan disease pathogenic factors: protective action of selenium and vitamin E. Metabolism 1998, 47(4):415-419.
26. Ferrans V.J., Van Vleet J.F. Cardiac lesions of selenium-vitamin E deficiency in animals. Heart Vessels Suppl 1985, 1:294-297.
27. Schauer J.E., Schelin A., Hanson P., Stratman F.W. Dehydroepiandrosterone and a beta-agonist, energy transducers, alter antioxidant enzyme systems: influence of chronic training and acute exercise in rats. Arch Biochem Biophys 1990, 283(2):503-511.
28. Aragno M., Brignardello E., Tamagno E., Gatto V., Danni O., Boccuzzi G. Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J Endocrinol 1997, 155(2):233-240.
29. Boccuzzi G., Aragno M., Seccia M., Brignardello E., Tamagno E., Albano E., et al. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic Biol Med 1997, 22(7):1289-1294.
30. Tamagno E., Aragno M., Boccuzzi G., Gallo M., Parola S., Fubini B., et al. Oxygen free radical scavenger properties of dehydroepiandrosterone. Cell Biochem Funct 1998, 16:57-63.
31. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984, 59(3):551-555.
32. Lavrovsky Y., Chatterjee B., Clark R.A., Roy A.K. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000, 35:521-532.
33. Chen S., Khan Z.A., Cukiernik M., Chakrabarti S. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 2003, 284(6):E1089-E1097.